clinical trial · NCT04670666
Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus
EMS·phase3·recruiting·n = 270
Type 2 Diabetes MellitusMADALENA ASSOCIATIONMETFORMINEMPAGLIFLOZIN + LINAGLIPTINMADALENA ASSOCIATION PLACEBOMETFORMIN PLACEBOEMPAGLIFLOZIN + LINAGLIPTIN PLACEBO
brief summary
The purpose of this study is to evaluate the efficacy and safety of Madalena association in the treatment of type 2 diabetes mellitus.
started
Nov 18, 2024
primary completion
Jul 1, 2026
completion
Jun 1, 2027
last updated
Dec 8, 2025
official title
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol